What's new? Log in Free sign up

Filing search / Moolec Science SA / "Research and Development"

Search information

Moolec Science SA

Companies

"Research and Development"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

33 results

Newest first Best match first

MLEC Moolec Science SA

Annual report (foreign)

development timeline and expected research and development (“R&D”); our ability to commercialize the products developed in our R&D center, acquired … , limit, reduce or terminate our manufacturing, research and development activities or growth and expansion plans; and delay, limit, reduce or terminate

30 Oct 24

2:53pm

MLEC Moolec Science SA

Moolec Science Presents Fiscal Year 2024 Annual Business Update

and Product Development: Research and development will continue to be a core component of Moolec’s business, adding new projects to the innovation … , we used $9,328.3 thousands of net cash in operating activities mainly related to research and development, selling and administrative costs

MLEC Moolec Science SA

Report of Foreign Private Issuer

. Research and development expense Note 21. Cost of sales Note 22. Net loss per share Note 23. Related parties Note 24. Financial instruments Note 25 … operations Revenue Cost of sales Other income Research and development expense Marketing expense Administrative expense Other operating expense Loss from

MLEC Moolec Science SA

Prospectus supplement

. Financial Debts Note 17. Financial income / expenses Note 18. Administrative expenses Note 19. Research and development expense Note 20. Cost of sales … Research and development expense Marketing expense Administrative expense Other operating expense Loss from operations Other Financial Results Financial

MLEC Moolec Science SA

Prospectus supplement

. Administrative expenses Note 19. Research and development expense Note 20. Cost of sales Note 21. Net loss per share Note 22. Related parties Note 23 … For the three months ended December 31 Continuing operations Revenue Cost of sales Other income Research and development expense Marketing expense

Report of Foreign Private Issuer

cylrrs xz63iying3ld6

Prospectus supplement

7ikdhf5kbwh7r3ks

Prospectus supplement

Report of Foreign Private Issuer

Prospectus supplement

Prospectus supplement

Prospectus update (post-effective amendment)

Prospectus update (post-effective amendment)

Annual report (foreign) (amended)

Annual report (foreign)

30 Oct 23

5:20pm

Prospectus supplement

amdepzy8i m9m873pyt

Prospectus supplement

l2lmk mz8itevltzd1xc

Report of Foreign Private Issuer

qek6hn39afh rt12w

Prospectus supplement

Moolec Science Presents Third Quarter FY 2023 Business Update

Prev
1
2
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.